Phase II study of apatinib in combination with oral vinorelbine in heavily pretreated HER2-negative metastatic breast cancer and clinical implications of monitoring ctDNA.
Zhu A, Yuan P, Hu N, Li M, Wang W, Wang X, Yue J, Wang J, Luo Y, Ma F, Zhang P, Li Q, Xu B, Cao S, Lippi G, Naito Y, Osman MA, Marta GN, Franceschini G, Orlandi A.
Zhu A, et al.
Cancer Biol Med. 2021 May 26;18(3):875-87. doi: 10.20892/j.issn.2095-3941.2020.0418. Online ahead of print.
Cancer Biol Med. 2021.
PMID: 34037346
Free PMC article.